ATF3 and Zika virus infectious disease: When we inhibited the ISR pathway during ZIKV infection using ISRIB, a broad ISR inhibitor (Fig. 3), or GSK2606414, a PERK inhibitor (data not shown), ATF4 protein expression was reduced, and ATF3 mRNA levels were negligible (Fig. 3, and data not shown).